Post-approval studies (Phase 4)Study completedNCT03426761
What this trial is testing
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
Who this might be right for
Bone InfectionOsteomyelitisSeptic Arthritis+2 more
Infectious Diseases Physicians, Inc. 41